HOME >> MEDICINE >> NEWS
Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer

Working with human colorectal cancer cells, a University of Minnesota team, led by cancer biologists Zigang Dong and Ann Bode, has found the potential culprit among a network of enzymes that relay signals inside cells to regulate such functions as cell growth, cancer development and programmed cell death. The work suggests that drugs designed to disable the enzyme, known as TOPK, could have anti-cancer benefits. The study appears in the July issue of the journal Gastroenterology.

Colorectal [cancer] is the second leading cause of cancer mortality, and the molecular pathways [by which it develops] remain incompletely understood, said Dong, a McKnight Presidential Professor in cancer prevention and director of the universitys Hormel Institute in Austin, Minn. In this study, we provided evidence showing that TOPK promotes transformation [of normal cells to cancerous ones] in colorectal carcinoma.

The story begins with the frequent observation by researchers that members of this enzyme network are overactive in the cells of several human cancers. The function of all these enzymes is to activate other enzymes and proteins, which makes them ideal for passing along signals.

For example, a cancer-causing agent or a hormone may find its way from the bloodstream to the outer membrane of a cell. After its arrival, it sets off a chain of reactions, or signals, inside the cell. Some of these signals take the form of certain enzymes activating others. Eventually, the news reaches the genetic material inside the cell nucleus, where changes resulting in uncontrolled growth--cancer--or some other cell behavior are made.

It was thought that some form of an enzyme called MEK, which belongs to the family of signaling enzymes, was the culprit. But to cause cancer, an enzyme or other agent is expected to be active all the time, like a light with no off switch. MEK, however, is never active all the time in nature; only if kept artificially activ
'"/>

Contact: David Ruth
druth@umn.edu
612-624-1690
University of Minnesota
31-Jul-2007


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
8. Study outlines how stroke, head injury can increase risk of Alzheimers disease
9. Study identifies new regulator of fat metabolism
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Study examines characteristics of female high school students who report steroid use

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2019)... NEW ORLEANS (PRWEB) , ... June 19, 2019 , ... ... using mothers in the United States, has filed class action lawsuits in 34 ... Named as defendants in the class actions are an array of pharmaceutical manufacturers, distributors ...
(Date:6/18/2019)... ... , ... EMulate Therapeutics, Inc. , a clinical-stage therapeutic ... has received notice that the US Food and Drug Administration (FDA) accepted for ... Pediatric system. The FDA granted the Humanitarian Use Device (HUD) designation for ...
(Date:6/16/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... June 14, ... ... Data Protection / Cyber Security solutions, today announced it has received the ... showcasing the award winning DLP that Works Platform along with the latest additions ...
(Date:6/14/2019)... ... 2019 , ... Docs is proud to present the following recently reviewed and approved providers for May 2019. , FL ... , BREAST SURGERY, Dr. Debbie Berlin , CARDIOLOGY, ... Dr. Christopher J. Pastore , Dr. Yamilet Tirado , DERMATOLOGY, ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... Second Test (BL30SEC) has been accepted by the 2019 National Conference of Interstate ... N requirements. , The Charm BL30SEC test was validated by third party ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... Recent lawsuits, including Hyatt ... back problem, underscore the responsibility of employers to provide reasonable accommodations to their ... are reasonable and which are not - from requests by hearing-impaired and disabled ...
(Date:6/13/2019)... ATLANTA (PRWEB) , ... June 13, 2019 , ... ... is celebrating 10 years of educating medical professionals and the public about non-invasive ... PBM this fall in Orlando, Florida to help commemorate the milestone. ...
(Date:6/13/2019)... ... June 13, 2019 , ... HMP, a leading healthcare education and events company, ... “Top 25 Fastest-Growing Shows in Net Square Footage” by Trade Show News Network (TSNN). ... growth over that period. Winners will be honored during the 2019 TSNN Awards, taking ...
Breaking Medicine Technology:
Cached News: